Skip to main content

Table 3 Wilcoxon sign-rank test was used to test the difference between pre-PP1M and Post-PP1M. Comparison of Direct Cost for patients with ≥ 1 Inpatient Stay in 1 Year Pre-PP1M Treatment with OAPs

From: A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China

  Medicine costs Hospitalization costs Direct costs
pre-PP1M (¥) 8992±3414 25,656±18,756 34,700±18,044
Post-PP1M (¥) 21,961±5492 7179±10,552 27,705±8266
Difference 144% -72.02% -20.16%
P < 0.01 < 0.01 < 0.01